Insight Molecular Diagnostics (IMDX) Assets Growth (1y) (2016 - 2026)
Insight Molecular Diagnostics (IMDX) Assets Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 212.96 Bn | 208.90 Bn | 8.34 Bn |
| 2 | Danaher | 139.30 Bn | 134.95 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.15 Bn | 45.95 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.40 Bn | 37.59 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 38.20 Bn | 36.12 Bn | 1.44 Bn |
| 6 | Natera | 37.79 Bn | 36.69 Bn | 696.04 Mn |
| 7 | Illumina | 28.65 Bn | 27.49 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.40 Bn | 28.35 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.32 Bn | 25.69 Bn | 1.03 Bn |
| 10 | Insight Molecular Diagnostics | 170.35 Mn | 141.42 Mn | 15,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -33.02% |
| Dec 31, 2025 | -26.58% |
| Sep 30, 2025 | -37.43% |
| Jun 30, 2025 | -32.39% |
| Mar 31, 2025 | -14.95% |
| Dec 31, 2024 | -53.16% |
| Sep 30, 2024 | -13.94% |
| Jun 30, 2024 | -14.64% |
| Mar 31, 2024 | -14.28% |
| Dec 31, 2023 | -25.18% |
| Sep 30, 2023 | -48.15% |
| Jun 30, 2023 | -48.82% |
| Mar 31, 2023 | -43.39% |
| Dec 31, 2022 | -37.27% |
| Sep 30, 2022 | -6.53% |
| Jun 30, 2022 | -3.57% |
| Mar 31, 2022 | 13.12% |
| Dec 31, 2021 | 187.92% |
| Sep 30, 2021 | 191.37% |
| Jun 30, 2021 | 179.54% |